1

China Pharma

China Pharma
Leadership team

Ms. Zhilin Li (Pres, CEO, Chairman & Interim CFO)

Ms. Huang Na C.F.A. (BOD Sec. & IR Mang.)

Products/ Services
Biotechnology, Health Care, Manufacturing, Therapeutics
Number of Employees
100 - 500
Headquarters
Hainan, Hainan, China
Established
1999
Company Registration
SEC CIK number: 0001106644
Revenue
5M - 20M
Traded as
NYSEAMERICAN:CPHI
Overview
Location
Summary
China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products primarily to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. Its products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylgallate and Ozagrel Sodium to treat cerebral thrombosis, coronary heart disease, and after surgery complications; Alginic Sodium Diester injection for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Bumetanide injection to treat edema diseases; and Candesartan for hypertension. It also provides Roxithromycin dispersible tablets for pharyngitis and tonsillitis; Cefaclor dispersible tablets for tympanitis, lower respiratory tract infection, urinary tract infections, and skin/skin tissue infection; Cefalexin capsules for acute tonsillitis; Andrographolide for sore throat caused by upper respiratory tract infection; Clarithromycin granules and capsules; and Naproxen Sodium and PseudophedrineHydrochlorida sustained release tablets. In addition, the company offers Hepatocyte growth-promoting factor, Tiopronin, Compound Ammonium Glycyrrhetate S, and Omeparzole for the treatment of digestive diseases. Further, it provides Vitamin B6 injection; Granisetron Hydrochloride injection to treat nausea and vomiting caused by radiotherapy and chemotherapy during the treatment of malignant tumors; Noni Enzyme, a food supplement; sanitizers; and masks. The company offers its products through distributors, as well as through its network of 16 sales offices and approximately 1,000 sales representatives. China Pharma Holdings, Inc. was founded in 1993 and is based in Haikou, the People's Republic of China.
History

China Pharma Holdings, Inc. was founded in August 1996 and is headquartered in Hangzhou, China. The Company and its subsidiaries operate a fully-integrated specialty pharmaceutical business in China, with raw material procurement, research and development, active pharmaceutical ingredient (API) and finished dosage production, marketing and distribution capabilities.

Mission
Our Company is dedicated to being a leading Chinese specialty pharmaceutical company by providing high quality medicines, products and services to our customers with a commitment to excellence and safety, and by acting with accountability and integrity.
Vision
We strive to be the health care provider of choice for our patients to improve their health and well-being.
Key Team

Ms. Zhilin Li (Pres, CEO, Chairman & Interim CFO)

Ms. Huang Na C.F.A. (BOD Sec. & IR Mang.)

Recognition and Awards
China Pharma Holdings, Inc. has received numerous awards for its innovation in the specialty pharmaceutical business and contributions to the Chinese health care system.
References

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

China Pharma
Leadership team

Ms. Zhilin Li (Pres, CEO, Chairman & Interim CFO)

Ms. Huang Na C.F.A. (BOD Sec. & IR Mang.)

Products/ Services
Biotechnology, Health Care, Manufacturing, Therapeutics
Number of Employees
100 - 500
Headquarters
Hainan, Hainan, China
Established
1999
Company Registration
SEC CIK number: 0001106644
Revenue
5M - 20M
Traded as
NYSEAMERICAN:CPHI